Accenture: The Market Is Pricing In Too Much Permanent Damage

Accenture trades at 12x FY26 earnings after a 40% decline, offering a 4% yield and cautious Buy rating. Organic growth is weak, bookings have declined, and Capgemini's superior performance highlights ACN's execution issues rather than just industry headwinds. AI is both a threat and opportunity; ACN's AI initiatives and Edge unit show promise, but scale and margin impact remain unproven. The $9B acquisition program introduces integration risk, but robust free cash flow and shareholder returns provide downside protection at current valuation.

Accenture ( ACN ) has gone from one of the market’s most dependable compounders to one of its most unpopular stocks. The shares have fallen approximately 40% and now trade at around 12 times expected fiscal